Literature DB >> 25900396

Delineation of the KIAA2022 mutation phenotype: two patients with X-linked intellectual disability and distinctive features.

Yukiko Kuroda1, Ikuko Ohashi1, Takuya Naruto1, Kazumi Ida1, Yumi Enomoto1, Toshiyuki Saito2, Jun-Ichi Nagai2, Takahito Wada3, Kenji Kurosawa1.   

Abstract

Next-generation sequencing has enabled the screening for a causative mutation in X-linked intellectual disability (XLID). We identified KIAA2022 mutations in two unrelated male patients by targeted sequencing. We selected 13 Japanese male patients with severe intellectual disability (ID), including four sibling patients and nine sporadic patients. Two of thirteen had a KIAA2022 mutation. Patient 1 was a 3-year-old boy. He had severe ID with autistic behavior and hypotonia. Patient 2 was a 5-year-old boy. He also had severe ID with autistic behavior, hypotonia, central hypothyroidism, and steroid-dependent nephrotic syndrome. Both patients revealed consistent distinctive features, including upswept hair, narrow forehead, downslanting eyebrows, wide palpebral fissures, long nose, hypoplastic alae nasi, open mouth, and large ears. De novo KIAA2022 mutations (p.Q705X in Patient 1, p.R322X in Patient 2) were detected by targeted sequencing and confirmed by Sanger sequencing. KIAA2022 mutations and alterations have been reported in only four families with nonsyndromic ID and epilepsy. KIAA2022 is highly expressed in the fetal and adult brain and plays a crucial role in neuronal development. These additional patients support the evidence that KIAA2022 is a causative gene for XLID.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  KIAA2022; X-linked intellectual disability; next-generation sequencing; targeted sequencing

Mesh:

Substances:

Year:  2015        PMID: 25900396     DOI: 10.1002/ajmg.a.37002

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  11 in total

1.  NEXMIF/KIDLIA Knock-out Mouse Demonstrates Autism-Like Behaviors, Memory Deficits, and Impairments in Synapse Formation and Function.

Authors:  James Gilbert; Margaret O'Connor; Sebastian Templet; Mahsa Moghaddam; Anaïs Di Via Ioschpe; Amanda Sinclair; Ling-Qiang Zhu; Weifeng Xu; Heng-Ye Man
Journal:  J Neurosci       Date:  2019-11-08       Impact factor: 6.167

2.  RLIM Is a Candidate Dosage-Sensitive Gene for Individuals with Varying Duplications of Xq13, Intellectual Disability, and Distinct Facial Features.

Authors:  Elizabeth E Palmer; Renee Carroll; Marie Shaw; Raman Kumar; Andre E Minoche; Melanie Leffler; Lucinda Murray; Rebecca Macintosh; Dale Wright; Chris Troedson; Fiona McKenzie; Sharron Townshend; Michelle Ward; Urwah Nawaz; Anja Ravine; Cassandra K Runke; Erik C Thorland; Marybeth Hummel; Nicola Foulds; Olivier Pichon; Bertrand Isidor; Cédric Le Caignec; Bénédicte Demeer; Joris Andrieux; Salam Hadah Albarazi; Ann Bye; Rani Sachdev; Edwin P Kirk; Mark J Cowley; Mike Field; Jozef Gecz
Journal:  Am J Hum Genet       Date:  2020-11-06       Impact factor: 11.025

3.  Clonazepam as an Effective Treatment for Epilepsy in a Female Patient with NEXMIF Mutation: Case Report.

Authors:  Masashi Ogasawara; Eiji Nakagawa; Eri Takeshita; Kohei Hamanaka; Satoko Miyatake; Naomichi Matsumoto; Masayuki Sasaki
Journal:  Mol Syndromol       Date:  2020-09-01

4.  Torpedo Maculopathy Associated with NEXMIF Mutation.

Authors:  Tuğba Alarcon-Martinez; Ayesha Khan; Kenneth A Myers
Journal:  Mol Syndromol       Date:  2019-03-15

Review 5.  Epileptic Encephalopathy in Childhood: A Stepwise Approach for Identification of Underlying Genetic Causes.

Authors:  Jaina Patel; Saadet Mercimek-Mahmutoglu
Journal:  Indian J Pediatr       Date:  2016-01-29       Impact factor: 1.967

6.  Novel NEXMIF pathogenic variant in a boy with severe autistic features, intellectual disability, and epilepsy, and his mildly affected mother.

Authors:  Nelle Lambert; Corinne Dauve; Emmanuelle Ranza; Periklis Makrythanasis; Federico Santoni; Frédérique Sloan-Béna; Stefania Gimelli; Jean-Louis Blouin; Michel Guipponi; Armand Bottani; Stylianos E Antonarakis; Markus M Kosel; Joel Fluss; Ariane Paoloni-Giacobino
Journal:  J Hum Genet       Date:  2018-05-01       Impact factor: 3.172

7.  The X-Linked Autism Protein KIAA2022/KIDLIA Regulates Neurite Outgrowth via N-Cadherin and δ-Catenin Signaling.

Authors:  James Gilbert; Heng-Ye Man
Journal:  eNeuro       Date:  2016-10-28

Review 8.  Fundamental Elements in Autism: From Neurogenesis and Neurite Growth to Synaptic Plasticity.

Authors:  James Gilbert; Heng-Ye Man
Journal:  Front Cell Neurosci       Date:  2017-11-20       Impact factor: 5.505

9.  Clinical exome sequencing: results from 2819 samples reflecting 1000 families.

Authors:  Daniel Trujillano; Aida M Bertoli-Avella; Krishna Kumar Kandaswamy; Maximilian Er Weiss; Julia Köster; Anett Marais; Omid Paknia; Rolf Schröder; Jose Maria Garcia-Aznar; Martin Werber; Oliver Brandau; Maria Calvo Del Castillo; Caterina Baldi; Karen Wessel; Shivendra Kishore; Nahid Nahavandi; Wafaa Eyaid; Muhammad Talal Al Rifai; Ahmed Al-Rumayyan; Waleed Al-Twaijri; Ali Alothaim; Amal Alhashem; Nouriya Al-Sannaa; Mohammed Al-Balwi; Majid Alfadhel; Arndt Rolfs; Rami Abou Jamra
Journal:  Eur J Hum Genet       Date:  2016-11-16       Impact factor: 4.246

10.  De novo mutations of KIAA2022 in females cause intellectual disability and intractable epilepsy.

Authors:  Iris M de Lange; Katherine L Helbig; Sarah Weckhuysen; Rikke S Møller; Milen Velinov; Natalia Dolzhanskaya; Eric Marsh; Ingo Helbig; Orrin Devinsky; Sha Tang; Heather C Mefford; Candace T Myers; Wim van Paesschen; Pasquale Striano; Koen van Gassen; Marjan van Kempen; Carolien G F de Kovel; Juliette Piard; Berge A Minassian; Marjan M Nezarati; André Pessoa; Aurelia Jacquette; Bridget Maher; Simona Balestrini; Sanjay Sisodiya; Marie Therese Abi Warde; Anne De St Martin; Jamel Chelly; Ruben van 't Slot; Lionel Van Maldergem; Eva H Brilstra; Bobby P C Koeleman
Journal:  J Med Genet       Date:  2016-06-29       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.